The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients—Absence of Evidence or Evidence of Absence?
Abstract
Although it is beyond any doubt that smoking is the number one preventable cause of death in most countries, smoking as an independent progression factor in renal disease has been questioned against the background of evidence-based criteria. This is because information from large, randomized, prospective studies that investigate the effects of smoking on renal function in healthy individuals as well as in patients with primary or secondary renal disease are lacking. Since 2003, a substantial number of clinical and experimental data concerning the adverse renal effects of smoking have been published, including large, prospective, population-based, observational studies. These more recent data together with evidence from experimental studies clearly indicate that smoking is a relevant risk factor, conferring a substantial increase in risk for renal function deterioration. This review summarizes the present knowledge about the renal risks of smoking as well as the increased cardiovascular risk caused by smoking in patients with chronic kidney disease. The conclusion is that smoking is an important renal risk factor, and nephrologists have to invest more efforts to motivate patients to stop smoking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
Selvin, E., & Erlinger, T. P. (2004) · Circulation · doi:10.1161/01.cir.0000137913.26087.f0 · Cited by 1,885
Blood Pressure and End-Stage Renal Disease in Men
Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., & Stamler, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340103 · Cited by 1,663
Chronic Kidney Disease and Mortality Risk: A Systematic Review
Tonelli, M., Wiebe, N., Culleton, B., House, A., Rabbat, C., Fok, M., McAlister, F., & Garg, A. X. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101085 · Cited by 1,658
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Adverse Health Effects of Chronic Exposure to Low-Level Cadmium in Foodstuffs and Cigarette Smoke
Satarug, S., & Moore, M. R. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6751 · Cited by 871
Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
Muntner, P., He, J., Hamm, L., Loria, C., & Whelton, P. K. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133745 · Cited by 829
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
Cheung, A. K., Sarnak, M. J., Yan, G., Dwyer, J. T., Heyka, R. J., Rocco, M. V., Teehan, B. P., & Levey, A. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00173.x · Cited by 777
Shlipak, M. G., Fried, L. F., Cushman, M., Manolio, T. A., Peterson, D., Stehman-Breen, C., Bleyer, A., Newman, A., Siscovick, D., & Psaty, B. (2005) · JAMA · doi:10.1001/jama.293.14.1737 · Cited by 735
Cited by
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Bankir, L., Bouby, N., & Ritz, E. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.22 · Cited by 214
Yu, Z., Coresh, J., Qi, G., Grams, M., Boerwinkle, E., Snieder, H., Teumer, A., Pattaro, C., Köttgen, A., Chatterjee, N., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.044 · Cited by 135
Jhee, J. H., Joo, Y. S., Kee, Y. K., Jung, S.-Y., Park, S., Yoon, C.-Y., Han, S. H., Yoo, T.-H., Kang, S.-W., & Park, J. T. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09540818 · Cited by 60
Metadata
- Authors
- Orth, S. R., & Hallan, S. I.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2008-01
- Volume
- 3
- Issue
- 1
- Pages
- 226-236
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2159773815
- Cited by
- 290
- References
- 106
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients—Absence of Evidence or Evidence of Absence? https://app.cochat.ai/papers/10.2215/cjn.03740907
- The paper
- Orth, S. R., & Hallan, S. I. (2008). Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients—Absence of Evidence or Evidence of Absence? Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.03740907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.